Kanagawa, Japan

Atsushi Tsuruta

USPTO Granted Patents = 2 

Average Co-Inventor Count = 7.8

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Chuo-ku, JP (2020)
  • Kanagawa, JP (2022)

Company Filing History:


Years Active: 2020-2022

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovation in Medicine: The Contributions of Atsushi Tsuruta

Introduction

Atsushi Tsuruta, an esteemed inventor based in Kanagawa, Japan, has made significant strides in the field of medicinal chemistry. With a remarkable two patents to his name, he has dedicated his career to developing innovative solutions for serious health conditions, particularly those requiring specialized treatments.

Latest Patents

Tsuruta's most recent patents showcase his commitment to improving patient care in the realm of dialysis. The first is a medicinal composition for preventing or treating secondary hyperparathyroidism under maintenance dialysis. This innovative composition comprises 3-{[(2S)-2-amino-2-carboxyethyl]carbamoylamino}-5-chloro-4-methylbenzenesulfonic acid or a pharmaceutically acceptable salt thereof. It is designed to be administered through a predefined route and dosage. Notably, this composition aims to provide a prophylactic or therapeutic agent that exhibits reduced side effects and minimal accumulation, making it a safer option compared to conventional products.

Additionally, Tsuruta holds a patent for substituted benzenesulfonamides as inhibitors of alpha-4 beta-7 integrin activity. This invention describes a compound featuring α4 integrin inhibitory action, represented by a sulfonamide derivative formula, which is pivotal in the treatment of various diseases influenced by integrin interactions.

Career Highlights

Tsuruta is currently associated with Ea Pharma Co., Ltd., where he continues to innovate in pharmaceutical compositions. His contributions to the field are not only recognized in patents but also resonate within the medical community, paving the way for safer and more effective treatment options.

Collaborations

Throughout his career, Tsuruta has collaborated with esteemed colleagues such as Munetaka Tokumasu and Masatsugu Noguchi. These partnerships reflect his commitment to teamwork in driving the boundaries of medicinal innovation and enhancing therapeutic efficacy through collaborative efforts.

Conclusion

Atsushi Tsuruta's contributions to medicinal chemistry are a testament to his dedication and ingenuity as an inventor. Through his patents, he has provided valuable advancements that are likely to improve patient outcomes in dialysis and beyond. His work exemplifies the essence of innovation in the medical field, showcasing how dedicated inventors can significantly impact healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…